Cell-Based Assays

Evaluating Antibody Detection Methods in Myasthenia Gravis: Insights from the ADAM Study

The ADAM Study demonstrates superior diagnostic accuracy of live cell-based assays over fixed cell-based and ELISA tests for detecting AChR antibodies in myasthenia gravis, highlighting important clinical implications for antibody testing s